Skip to main content
DongKoo Bio & Pharma Co., Ltd. logo

DongKoo Bio & Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 006620 ISIN · KR7006620009 KO Manufacturing
Filings indexed 212 across all filing types
Latest filing 2021-02-26 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 006620

About DongKoo Bio & Pharma Co., Ltd.

https://www.dongkoo.com/eng/

DongKoo Bio & Pharma Co., Ltd. is a biopharmaceutical company that manufactures and sells a range of pharmaceuticals and health supplements. The company holds a leading position in the dermatology prescription market, with a product portfolio that includes antihistamines, analgesics, antipyretics, and digestants. Strategically expanding beyond traditional pharmaceuticals, DongKoo Bio & Pharma is focused on the biotechnology sector, particularly the development of stem cell-based therapies. This growth is pursued through an "Open Innovation" model to build a pipeline of differentiated products, supported by its research centers and PIC/s compliant GMP manufacturing facilities.

Recent filings

Filing Released Lang Actions
권리락(무상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a short announcement regarding a 'rights off' (권리락) event due to a bonus issue (무상증자) for Dongkoo Bio & Pharma. This type of corporate action announcement regarding capital changes and share adjustments falls under the category of share issues or capital changes.
2021-02-26 Korean
주요사항보고서(무상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean Financial Services Commission/Korea Exchange regarding a 'Decision on Bonus Issue' (무상증자결정). This involves a change in the company's capital structure through the issuance of new shares. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'Share Issue/Capital Change' (SHA) category.
2021-02-15 Korean
주권매매거래정지(무상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a short regulatory notice regarding the temporary suspension of stock trading for Dongkoo Bio & Pharma due to a bonus issue (무상증자). It cites KOSDAQ market regulations and provides specific suspension times. Since it is a regulatory announcement regarding trading status and does not fit into specific categories like share issuance or delisting, it falls under the general regulatory filing category.
2021-02-15 Korean
주주명부폐쇄기간또는기준일설정
Share Issue/Capital Change Classification · 100% confidence The document is a formal notice regarding the suspension of share registration (shareholder register closure) for Dongkoo Bio & Pharma. It specifies the record date, the period of suspension, and the reason (bonus issue/free capital increase). This type of regulatory disclosure regarding capital structure changes and shareholder rights falls under general regulatory announcements.
2021-02-15 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice regarding the suspension of share registration (shareholder register closure) for Dongkoo Bio & Pharma. It specifies the record date and the purpose, which is to determine shareholders for the upcoming 38th Annual General Meeting. Since this is a standard regulatory announcement regarding corporate administrative procedures and does not fit into specific categories like dividend announcements or financial reports, it is classified as a general regulatory filing.
2020-12-14 Korean
수시공시의무관련사항(공정공시)(2020년 사업연도(제38기) 현금배당 계획)
Notice of Dividend Amount Classification · 100% confidence The document is an official announcement from Dongkoo Bio & Pharma regarding their planned cash dividend for the 2020 fiscal year. It specifies the dividend amount per share, the record date, and the total dividend amount. This falls directly under the definition of a 'Notice of Dividend Amount' (DIV).
2020-12-08 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.